Program Overview

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of new advances. In addition, targeted therapies and oral treatments bring new benefits to patients. This program will focus on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

Highlights include*:

• Acute Myeloid Leukemia (AML)
• Chronic Myelogenous Leukemia (CML)
• Multiple Myeloma (MM)
• Myelodysplastic Syndrome (MDS)
• Non-Hodgkin’s Lymphoma (NHL)
• Supportive Care for Patients with Hematologic Malignancies